Anuncia
  • (978) 942-5600
  • Info@anunciamedical.com
  • Home
  • ABOUT
    • The Anuncia Story
    • Meet the Team
  • REFLOW
    • Our Technology
  • RESOURCES
    • News & Blogs
    • Professional Associations
    • Publications
  • HYDROCEPHALUS
    • What is Hydrocephalus?
    • Patient Resources
  • Contact
  • Menu Menu
admin

About admin

This author has not written his bio yet.
But we are proud to say that admin contributed 9 entries already.

Entries by admin

Anuncia Medical honored as participant in the 2022 Flinn Foundation Bioscience Entrepreneurship Program

March 30, 2022

Anuncia Medical, Inc. recognized as an Arizona bioscience startup to watch in 2022 SCOTTSDALE, Ariz., March 30, 2022 /PRNewswire/ — Anuncia Medical, Inc., a medtech startup developing neurotherapeutic devices for treatment of hydrocephalus and other neurological disorders, has been selected as one of seven Arizona early-stage bioscience companies to participate in the 2022 Flinn Foundation Bioscience Entrepreneurship Program. A total of 54 […]

Anuncia Medical, Inc. Selects Scottsdale, Ariz. for New HQ to Further Develop Lifesaving Medtech

June 30, 2021

Move provides emerging leader in innovation with opportunity to scale and access R&D, Bioscience & Healthcare ecosystem talent LOWELL, Mass., June 30, 2021 – Anuncia Inc., a therapeutic medical device company and an emerging leader in cerebrospinal fluid (CSF) management innovation, announced today it is moving its headquarters to Scottsdale, Ariz. and will operate at SkySong, the Arizona […]

The Ultimate List of Attractive MedTech M&A Targets

May 12, 2021

These are the companies in the private sector that medtech analysts have called attention to in 2021. Updated May 12, 2021 to reflect 10 new additions, based on recent analyst reports. We’ve also updated the existing companies on the list to reflect recent business developments. From time to time, medtech analysts will call out companies in […]

Anuncia ReFlow™ Tech Honored With Fast Company 2021 World Changing Ideas Awards

May 4, 2021

Anuncia’s breakthrough technology has received an honorable mention in the Health category of this year’s World Changing Ideas Awards LOWELL, Mass., May 4, 2021 – Anuncia Inc., an emerging leader in cerebrospinal fluid (CSF) management, received an Honorable Mention in the Health category of Fast Company’s 2021 World Changing Ideas Awards for its ReFlow™ medical device platform. […]

Anuncia Inc. Receives FDA “Breakthrough Device Designation” for ReFlow™ System Mini

March 2, 2021

LOWELL, Mass., March 2, 2021 /PRNewswire/ — Anuncia Inc., an emerging leader in Cerebral Spinal Fluid (CSF) management, received U.S. Food and Drug Administration (FDA) Breakthrough Device Designation for its ReFlow™ System Mini intended for the treatment of CSF disorders requiring shunting such as hydrocephalus, a debilitating and life-threatening condition affecting more than 1 million U.S. patients. Elsa Abruzzo, […]

Looking to the Future of Neuro Devices: Exclusive Interview with Alcyone Lifesciences CEO PJ Anand

May 7, 2019

Alcyone Lifesciences is a medical technology company based out of Lowell, MA, which specializes in central nervous system (CNS) drug delivery platforms for targeted infusions of the brain or spinal cord. Their Thecaflex DRx System was recently awarded Breakthrough Device designation by the FDA, for spinal infusion of therapeutic medications. Medgadget had the opportunity to speak with Alcyone Lifesciences CEO, PJ […]

First-in-Human Use of ReFlow™ for Treatment of Hydrocephalus

December 22, 2018

LOWELL, Mass., May 22, 2018 /PRNewswire/ — Anuncia, Inc., a privately-held company focused on better treatment of hydrocephalus and cerebrospinal fluid dysfunctions, announced, today, the successful first-in-human implantation of its Alivio ReFlow™ Ventricular System for treatment of hydrocephalus at Boston Children’s Hospital. This announcement comes on the heels of receiving the EU CE Mark and US FDA […]

Brain emergency averted at the push of a button

May 29, 2018

A Boston neurosurgeon recently avoided doing emergency brain surgery on a young patient just by pressing on a new device. The Alivio ReFlow ventricular system was embedded beneath the scalp of the unidentified hydrocephalus patient. Comprised of a subcutaneous “flusher” component and a ventricular catheter, the device has a “relief membrane” backup feature at the catheter’s […]

Alcyone Lifesciences Completes Spin-Off of Hydrocephalus Business, Anuncia

February 20, 2018

Alcyone Lifesciences, Inc., announces the separation and spin-off of its Hydrocephalus business. The new company, known as Anuncia, Inc., is an independent company focused on innovative treatment of Hydrocephalus and cerebrospinal fluid dysfunctions. LOWELL, Mass., Feb. 20, 2018 /PRNewswire/ — Alcyone Lifesciences, Inc., a privately-held company focused on transforming disease modifying therapies for central nervous […]

Pages

  • Contact
  • Cookie Policy
  • Home
  • News & Blogs
  • Our Technology
  • Patient Resources
  • Privacy Policy
  • Professional Associations
  • Publications
  • Thank You!
  • The Anuncia Story
  • What is Hydrocephalus?

Categories

  • Uncategorized

Archive

  • March 2022
  • June 2021
  • May 2021
  • March 2021
  • May 2019
  • December 2018
  • May 2018
  • February 2018

Our Address

SkySong Innovation Center Bldg. #4
1355 N Scottsdale Rd, Suite 370
Scottsdale, Arizona 85257

Directions

Follow Us:

Disclaimer

The ReFlow Ventricular System is FDA cleared and CE Marked for use by a qualified clinician to facilitate a safe, noninvasive retrograde fluid flush when ventriculoperitoneal shunt flow is restricted or blocked. The ReFlow System Mini is under development and not available for sale. The ReFlow System is a prescription device sold by or on the order of a physician.

Trademark Legal Notice

All logos, and brands are property of their respective owners in the United States and/or other countries. All company, product and service names used on this website are for identification purposes only. Use of these names, logos, and brands does not imply endorsement.
Anuncia Inc. is not affiliated with or an official partner of MD&DI, Fast Company, and The FDA.

© 2022 Anuncia Inc. All Rights Reserved. Website by Honeywick   |   Privacy Policy   |   Cookie Policy
Scroll to top